FHCCX
Price
$37.74
Change
+$0.24 (+0.64%)
Updated
Jul 25 closing price
Net Assets
3.35B
JNGLX
Price
$67.24
Change
+$0.25 (+0.37%)
Updated
Jul 25 closing price
Net Assets
4.4B
Interact to see
Advertisement

FHCCX vs JNGLX

Header iconFHCCX vs JNGLX Comparison
Open Charts FHCCX vs JNGLXBanner chart's image
Fidelity Advisor Health Care C
Price$37.74
Change+$0.24 (+0.64%)
VolumeN/A
Net Assets3.35B
Janus Henderson Global Life Sciences D
Price$67.24
Change+$0.25 (+0.37%)
VolumeN/A
Net Assets4.4B
FHCCX vs JNGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FHCCX vs. JNGLX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHCCX is a Hold and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. FHCCX (3.35B). JNGLX pays higher dividends than FHCCX: JNGLX (0.36) vs FHCCX (0.00). FHCCX was incepted earlier than JNGLX: FHCCX (28 years) vs JNGLX (27 years). FHCCX (1.69) is less costly to investors than JNGLX (0.80). FHCCX is a more actively managed with annual turnover of: 37.00 vs. JNGLX (35.00). FHCCX has a lower initial minimum investment than JNGLX: FHCCX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -14.43 vs. FHCCX (-20.18). JNGLX return over 5 years is better than : 4.98 vs. FHCCX (-21.35).
FHCCXJNGLXFHCCX / JNGLX
Total Expense Ratio1.690.80211%
Annual Report Gross Expense Ratio1.690.80211%
Fund Existence28 years27 years-
Gain YTD-3.797-1.326286%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.35B4.4B76%
Annual Yield % from dividends0.000.36-
Returns for 1 year-20.18-14.43140%
Returns for 3 years-11.038.83-125%
Returns for 5 years-21.354.98-429%
Returns for 10 years0.356.805%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFMX18.34N/A
N/A
Brown Advisory Mid-Cap Growth Instl
GHTMX15.40N/A
N/A
Goldman Sachs International T/M Eq Instl
MSGFX33.43N/A
N/A
Morgan Stanley Inst Global Franchise C
JGTUX43.90N/A
N/A
JPMorgan Growth Advantage R4
TRMNX22.61N/A
N/A
T. Rowe Price Mid-Cap Index